Proteon Therapeutics, Inc. Gains 30.5%
Thu 09 Jan 20 at 05:30 PM
Proteon Therapeutics, Inc. (PRTO:NASDAQ) shot up at $0.84, representing a gain of 30.5%. On Wed 08 Jan 20, PRTO:NASDAQ hit a New 2-Week High of $0.64. From Tue 17 Dec 19, the stock recorded 64.29% Up Days and 53.33% Green Days
About Proteon Therapeutics, Inc. (PRTO:NASDAQ)
Proteon Therapeutics Inc is an late-stage biopharmaceutical company engaged in the development of novel pharmaceuticals to address the needs of patients with renal and vascular disease.
Top 10 Gainers:
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 122.84%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 93.96%
- Genetic Technologies Limited (GENE:NASDAQ), 45.09%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 36.53%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 35.71%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 34.96%
- The Peck Company Holdings, Inc. (PECK:NASDAQ), 34.71%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 33.59%
- KemPharm, Inc. (KMPH:NASDAQ), 31.72%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%